More about

Ovarian Cancer

News
July 01, 2024
1 min watch
Save

VIDEO: Determining individual risk for ovarian cancer in primary care settings

In this video, Ronny Drapkin, MD, discusses identifying patients at heightened risk for ovarian cancer.

News
July 01, 2024
2 min watch
Save

VIDEO: Genetic, physiological factors that may increase ovarian cancer risk

In this video, Ronny Drapkin, MD, discusses known risk factors for ovarian cancer.

News
July 01, 2024
1 min watch
Save

VIDEO: PARP inhibitors ‘changed the way we think’ about ovarian cancer treatment

In this video, Ronny Drapkin, MD, discusses how PARP inhibitors changed the field of ovarian cancer treatment.

News
July 01, 2024
2 min watch
Save

VIDEO: Recent advancements in ovarian cancer treatment

In this video, Ronny Drapkin, MD, discusses recent advancements in ovarian cancer.

News
July 01, 2024
2 min watch
Save

VIDEO: Diagnostic challenges in ovarian cancer

In this video, Ronny Drapkin, MD, discusses challenges in diagnosing ovarian cancer.

News
June 12, 2024
3 min read
Save

Primary ovarian insufficiency, reproductive cancers may be linked across generations

BOSTON — People with primary ovarian insufficiency have higher risk for breast cancer and borderline increased risk for ovarian cancer compared with the general population, and risks for some cancers extend to their relatives, data show.

News
June 07, 2024
2 min read
Save

Endometriosis increases risks for ovarian, endometrial cancers

Endometriosis was significantly associated with higher risks for both ovarian and endometrial cancers, but was not significantly associated with cervical cancer risk, according to an analysis published in Current Oncology.

News
June 06, 2024
1 min read
Save

Trial of mirvetuximab soravtansine for ovarian cancer meets response rate endpoint

A trial investigating mirvetuximab soravtansine monotherapy in certain patients with platinum-sensitive ovarian cancer met its primary endpoint of improved objective response rate, according to the agent’s manufacturer.

News
May 24, 2024
3 min read
Save

Type of menopausal hormone therapy may influence cancer risk

CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.

News
May 19, 2024
2 min read
Save

Similar survival with fertility-sparing vs. non-sparing epithelial ovarian cancer surgery

SAN FRANCISCO — Nearly 20% of women of reproductive age with epithelial ovarian cancer undergo fertility-sparing surgery, which may not negatively affect overall survival, except in the case of high-grade endometrioid tumors, data show.

View more